USP drug classification [BR:br08302]
Genitourinary Agents
Antispasmodics, Urinary
Beta-3 Adrenergic Agonists
Vibegron
D10433 Vibegron (JAN/USAN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
25 Urogenital and anal organ agents
259 Miscellaneous
2590 Miscellaneous
D10433 Vibegron (JAN/USAN)
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D10433 Vibegron
Transporter substrate
DG01665 ABCB1 substrate
D10433 Vibegron
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
ADRB3
D10433 Vibegron (JAN/USAN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D10433
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D10433
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D10433
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D10433
Drug transporters
D10433